Connect with Key Stakeholders and Propel Curative Progress, Orphan Product Success and Patient Advocacy

Most amazing were the voices from the patient community who are driving drug discovery and access. What some doing for a few benefits us all in this rare space. CBI’s Summit was a prime example of how the patients are critical to informing the research and development dialogue but also vice versa. We need to know the innovations planned and in progress.

The rare Innovation summit is an intimate engaging meeting facilitating discussion amongst speakers and attendees – nice mix of industry and patient groups especially stakeholders I haven’t met before at other meetings.

The Rare Disease Innovation Summit provided the opportunity for cross communication between industry, nonprofits and vendors who bridge the gap between the two. From presentations to panels, every attendee walked away with new information and resources to help improve the quality of life for the rare disease community. Thank you for making this possible CBI!

The inaugural Rare Disease Innovation Conference brought together multidisciplinary stakeholders to discuss important issues challenging the rare disease ecosystem. The contributions by the audience accelerated thinking how to address and eventually resolve key access related issues impacting people in desperate need of therapeutic options.

Most amazing were the voices from the patient community who are driving drug discovery and access. What some doing for a few benefits us all in this rare space. CBI’s Summit was a prime example of how the patients are critical to informing the research and development dialogue but also vice versa. We need to know the innovations planned and in progress.

The rare Innovation summit is an intimate engaging meeting facilitating discussion amongst speakers and attendees – nice mix of industry and patient groups especially stakeholders I haven’t met before at other meetings.